Important Update Actualización importante:

Good news! All CHIP, STAR, and STAR Kids Member Handbooks are now available online. Quick, easy access to your benefits and coverage information - any time!

¡Buenas noticias! Todos los manuales para miembros de CHIP, STAR y STAR Kids ya están disponibles en línea. Obtén acceso rápido y sencillo a la información sobre tus beneficios y cobertura, ¡en cualquier momento!

Search

HHSC to Remove Oxbryta Products from all Formularies as of Oct. 17, 2024

Date: October 4, 2024
Attention: Providers
Effective date: October 10, 2024

Call to action: On September 25, 2024, Pfizer, the manufacturer voluntarily recalled all Oxbryta® (voxelotor) products from worldwide markets due to safety concerns.

Oxbryta will no longer be a covered benefit and will no longer be on the formulary starting October 17, 2024. 

ProductNDC No.
OXBRYTA 500 MG TABLET72786010101
OXBRYTA 300 MG TABLET FOR SUSP72786011102
OXBRYTA 300 MG TABLET FOR SUSP72786011103
OXBRYTA 300 MG TABLET72786010202
OXBRYTA 300 MG TABLET72786010203

Next step for Providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.